Waypoint Bio raih US$20 juta untuk terapi sel tervalidasi AI

Waypoint Bio is using spatial biology and AI to validate in vivo CAR-T candidates for solid tumors before costly clinical trials.

Waypoint Bio is using spatial biology and AI to validate in vivo CAR-T candidates for solid tumors before costly clinical trials.

Sinyal besarnya: AI bergerak dari demo ke anggaran, aturan, prosedur keamanan, dan alokasi modal.

Sumber: BusinessWire; BioSpace; Precision Medicine Online; CocoLoop, CocoLoop.